Trapidil inhibits platelet-derived growth factor-stimulated mitogen- activated protein kinase cascade

Hypertension

Volumn 31, Issue 2, 1998, Pages 665-671

  Hoshiya, Makiko ^a   Awazu, Midori ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Cyclic AMP; Growth factors, platelet derived; Kinases; Mitogenesis; Restenosis; Trapidil

Indexed keywords

ANTITHROMBOCYTIC AGENT; CYCLIC AMP; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; TRAPIDIL;

ANIMAL CELL; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; RESTENOSIS; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0031933969     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.2.665     Document Type: Article

References (30)

1. Schwartz RS, Holmes DR Jr, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol.. 1992; 20:1284-1293.
2. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 1991;253:1129-1132.
3. Ohnishi H, Yamaguchi K, Shimada S, Sato M, Funato H, Katsuki Y, Dabasaki T, Suzuki Y, Saitoh Y, Kumagai A. An evidence for 'response to injury' hypothesis. Life Sci. 1982;31:2595-2602.
4. Maresta A, Balducelli M, Cantini L, Casari A, Chioin R, Fabbri M, Fontanelli A, Monici Preti PA, Repetto S, Servi S, Varani E, for the STARC Investigators. Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty: results of the randomized, double-blind STARC study. Circulation. 1994;90:2710-2715.
5. Suzuki Y, Yamaguchi K, Shimada S, Kitamura Y, Ohnishi H. Anti-thrombotic activity and the mechanism of action of trapidil (Rocornal). Prostaglandins Leukot Med. 1982;9:685-691.
6. Kawamura T, Kitani T, Okajima Y, Okuda S, Urano S, Watada M, Nakagawa M, Ijichi H. Effect of trapidil on prostacyclin generation of arterial wall. Prostaglandins Med. 1980;5:113-121.
7. Cercek B, Ebrahimi R, Dimayuga P, Khorsandi M, Forrester JS. Trapidil prevents rat vascular smooth muscle cell proliferation in vitro and in vivo. J Am Coll Cardiol. 1991;17:72A. Abstract.
8. Gesualdo L, Di Paolo S, Ranieri E, Schena FP. Trapidil inhibits human mesangial cell proliferation: effect on PDGF β-receptor binding and expression. Kidney Int. 1994;46:1002-1009.
9. Claesson-Welsh L. Signal transduction by the PDGF receptors. Prog Growth Factor Res. 1994;5:37-54.
10. Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature. 1993;363: 45-51.
11. 2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. J Biol Chem. 1989;264:1146-1155.
12. Bokemeyer D, Sorokin A, Dunn MJ. Multiple intracellular MAP kinase signaling cascades. Kidney Int. 1996;49:1187-1198.
13. Mazurov AV, Menshikov MYu, Leytin VL, Tkachuk VA, Repin VS. Decrease of platelet aggregation and spreading via inhibition of the cAMP phosphodiesterase by trapidil. FEBS Lett. 1984;172:167-171.
14. Graves LM, Bornfeldt KE, Raines EW, Potts BC, MacDonald SG, Ross R, Krebs EG. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc Nat. Aca. Sci U S A. 1993;90:10300-10304.
15. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science. 1993;262:1065-1069.
16. Sorkin A, Westermark B, Heldin C-H, Claesson-Welsh L. Effect of receptor kinase inactivation on the rate of internalization and degradation of PDGF and the PDGF β-receptor. J Cell Biol. 1991;112:469-478.
17. Benjamin CW, Jones DA. Platelet-derived growth factor stimulates growth factor receptor binding protein-2 association with Shc in vascular smooth muscle cells. J Biol Chem. 1994;269:30911-30916.
18. Dickson B, Sprenger F, Morrison D, Hafen E. Raf functions downstream of Ras1 in the Sevenless signal transduction pathway. Nature. 1992;360: 600-603.
19. Valius M, Kazlauskas A. Phospholipase C-γ1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell. 1993;73:321-334.
20. Cobb MH, Boulton TG, Robbins DJ. Extracellular signal-regulated kinases: ERKs in progress. Cell Regul. 1991;2:965-978.
21. Molloy CJ, Pawlowski JE, Taylor DS, Turner CE, Weber H, Peluso M, Seiler SM. Thrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the Raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for an obligate autocrine mechanism promoting cell proliferation induced by G protein-coupled receptor agonists. J Clin Invest. 1996;97: 1173-1183.
22. Huwiler A, Fabbro D, Pfeilschifter JP. Platelet-derived growth factor stimulates de-novo synthesis of mitogen-activatcd protein kinase in renal mesangial cells. Eur J Biochem. 1995;227:209-213.
23. Huwiler A, Stabel S, Fabbro D, Pfeilschifter JP. Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: comparison of hypertrophic and hyperplastic agonists. Biochem J. 1995;305:777-784.
24. Pagès G, Lenormand P, L'Allemain G, Chambard J-C, Meloche S, Pouysségur J. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci U S A. 1993;90:8319-8323.
25. Zheng C-F, Guan K-L. Dephosphorylation and inactivation of the mitogen-activated protein kinase by a mitogen-induced Thr/Tyr protein phosphatase. J Biol Chem. 1993;268:16116-16119.
26. Matousovic K, Grande JP, Chini CCS, Chini EN, Dousa TP. Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells. J Clin Invest. 1995;96: 401-410.
27. Sun H, Charles CH, Lau LF, Tonks NK. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell. 1993;75:487-493.
28. Duff JL, Monia BP, Berk BC. Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. J Biol Chem. 1995;270:7161-7166.
29. Brondello J-M, Brunet A, Pouysségur J, McKenzie FR. The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade. J Biol Chem. 1997;272: 1368-1376.
30. Gibbons G, Dzau VJ. Molecular therapies for vascular diseases. Science. 1996;272:689-693.